China Biotech Services Holdings Limited reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was HKD 384.09 million compared to HKD 154.17 million a year ago. Net income was HKD 34.94 million compared to HKD 1.82 million a year ago. Basic earnings per share from continuing operations was HKD 0.036 compared to HKD 0.002 a year ago.